Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Feldman

Showing results (91-100 of 220) with videos related to

Pageof 22
Sort By:
The British Journal of Dermatology|May 25, 2021
Tildrakizumab: interpreting the dataC G Purvis, V K Emmerich, S R Feldman
Dermatology Online Journal|May 1, 2001
Acanthosis nigricans in obese patients: Presentations and implications for prevention of atherosclerotic vascular diseaseA S Katz, D C Goff, S R Feldman
Dermatologic Clinics|May 3, 2000
Introduction. The magnitude of skin disease in the United StatesA B Fleischer, S R Feldman, S R Rapp
Clinics in Geriatric Medicine|September 6, 2001
Demographics of aging and skin diseaseE S Smith, A B Fleischer, S R Feldman
Cancer|September 26, 2001
Lifestyle high-risk behaviors and demographics may predict the level of participation in sun-protection behaviors and skin cancer primary prevention in the United States: results of the 1998 National Health Interview SurveyB R Santmyire, S R Feldman, A B Fleischer
Journal of the American Academy of Dermatology|March 10, 1999
The gatekeeper model is inefficient for the delivery of dermatologic servicesS R Feldman, A B Fleischer, J G Chen
Annals of the New York Academy of Sciences|September 10, 1994
Receptors for alpha 2-macroglobulin are present on human dermal fibroblasts, but not on human keratinocytesS R Feldman, T Seo, R W St Clair
Archives of Dermatology|August 11, 1992
Fluconazole treatment of cutaneous cryptococcosisS R Feldman, A B Fleischer, S D Resnick
Journal of the American Academy of Dermatology|November 1, 1993
Tanning salon porokeratosisA B Fleischer, M J Donahue, S R Feldman
Skin Therapy Letter|September 19, 2015
Regulating off-label promotion of medications: has the pendulum swung too far?M B Hoffman, B A Yentzer, S R Feldman
Pageof 22

Showing results (91-100 of 220) with videos related to

Sort By:
Pageof 22
The British Journal of Dermatology|May 25, 2021
Tildrakizumab: interpreting the dataC G Purvis, V K Emmerich, S R Feldman
Dermatology Online Journal|May 1, 2001
Acanthosis nigricans in obese patients: Presentations and implications for prevention of atherosclerotic vascular diseaseA S Katz, D C Goff, S R Feldman
Dermatologic Clinics|May 3, 2000
Introduction. The magnitude of skin disease in the United StatesA B Fleischer, S R Feldman, S R Rapp
Clinics in Geriatric Medicine|September 6, 2001
Demographics of aging and skin diseaseE S Smith, A B Fleischer, S R Feldman
Cancer|September 26, 2001
Lifestyle high-risk behaviors and demographics may predict the level of participation in sun-protection behaviors and skin cancer primary prevention in the United States: results of the 1998 National Health Interview SurveyB R Santmyire, S R Feldman, A B Fleischer
Journal of the American Academy of Dermatology|March 10, 1999
The gatekeeper model is inefficient for the delivery of dermatologic servicesS R Feldman, A B Fleischer, J G Chen
Annals of the New York Academy of Sciences|September 10, 1994
Receptors for alpha 2-macroglobulin are present on human dermal fibroblasts, but not on human keratinocytesS R Feldman, T Seo, R W St Clair
Archives of Dermatology|August 11, 1992
Fluconazole treatment of cutaneous cryptococcosisS R Feldman, A B Fleischer, S D Resnick
Journal of the American Academy of Dermatology|November 1, 1993
Tanning salon porokeratosisA B Fleischer, M J Donahue, S R Feldman
Skin Therapy Letter|September 19, 2015
Regulating off-label promotion of medications: has the pendulum swung too far?M B Hoffman, B A Yentzer, S R Feldman
Pageof 22